Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125 I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial-Reference-Cited by-同舟云学术

Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125 I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial

Published:2020-06-26 Issue:9 Volume:27 Page:755-759
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Nakai Yasushi¹,Tanaka Nobumichi¹,Asakawa Isao²,Anai Satoshi¹,Miyake Makito¹,Morizawa Yosuke¹,Hori Shunta¹,Owari Takuya¹,Fujii Tomomi³,Ohbayashi Chiho³,Yamaki Kaori²,Hasegawa Masatoshi²,Fujimoto Kiyohide¹

Affiliation:

1. Departments ofDepartment of Urology Nara Medical University Kashihara Nara Japan

2. Department of Radiation Oncology Nara Medical University Kashihara Nara Japan

3. Department of Diagnostic Pathology Nara Medical University Kashihara Nara Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14294

Reference26 articles.

1. Cyclooxygenase‐2 expression in human esophageal carcinoma;Zimmermann KC;Cancer Res.,1999

2. Expression of cyclooxygenase‐2 in human gastric caricinoma;Ristimäki A;Cancer Res.,1997

3. Expression of cyclooxygenase‐1 and –2 in human colorectal cancer;Sano H;Cancer Res.,1995

4. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas;Hida T;Cancer Res.,1998

5. Immunohistochemical Expression of Ki-67 Antigen, Cox-2 and Bax/Bcl-2 in Prostate Cancer; Prognostic Value in Biopsies and Radical Prostatectomy Specimens

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics;Pharmacology & Therapeutics;2021-12

2. Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model;Scientific Reports;2021-10-13